Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vibeke Strand

Showing results (211-220 of 435) with videos related to

Pageof 44
Sort By:
Arthritis Research & Therapy|October 31, 2019
The impact of sex and disease classification on patient-reported outcome measures in axial spondyloarthritis: a descriptive prospective cross-sectional studyRikke A Andreasen, Lars E Kristensen, Kenneth Egstrup, et al.
The Journal of Rheumatology|July 15, 2023
Report of the Skin Research Workgroups From the IDEOM Breakout at the GRAPPA 2022 Annual MeetingMelissa P Zundell, Michael J Woodbury, Kathryn Lee, et al.
RMD Open|November 2, 2019
Patient-reported outcomes for tofacitinib with and without methotrexate, or adalimumab with methotrexate, in rheumatoid arthritis: a phase IIIB/IV trialVibeke Strand, Eduardo Mysler, Robert J Moots, et al.
RMD Open|October 19, 2016
Tofacitinib versus methotrexate in rheumatoid arthritis: patient-reported outcomes from the randomised phase III ORAL Start trialVibeke Strand, Eun Bong Lee, Roy Fleischmann, et al.
Seminars in Arthritis and Rheumatism|May 24, 2012
Proceedings of the 2012 Rheumatology Winter Clinical SymposiaArthur Kavanaugh, George Martin, John J Cush, et al.
Rheumatology (Oxford, England)|November 26, 2013
Epratuzumab for patients with moderate to severe flaring SLE: health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE trials and extension study SL0006Vibeke Strand, Michelle Petri, Kenneth Kalunian, et al.
European Journal of Rheumatology|November 3, 2018
Comparative effectiveness of secukinumab and adalimumab in ankylosing spondylitis as assessed by matching-adjusted indirect comparisonWalter P Maksymowych, Vibeke Strand, Peter Nash, et al.
The American Journal of Medicine|May 27, 2008
Tumor necrosis factor antagonist responsiveness in a United States rheumatoid arthritis cohortJeffrey D Greenberg, Mitsumasa Kishimoto, Vibeke Strand, et al.
The Journal of Rheumatology|July 15, 2024
Report of the IDEOM Meeting Adjacent to the GRAPPA 2023 Annual MeetingGretchen D Ball, Danielle Yee, Arianna J Zhang, et al.
Rheumatology and Therapy|October 18, 2021
Patient-Reported Outcomes in Psoriatic Arthritis Patients with an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drugs: SELECT-PsA 2Vibeke Strand, Filip Van den Bosch, Roberto Ranza, et al.
Pageof 44

Showing results (211-220 of 435) with videos related to

Sort By:
Pageof 44
Arthritis Research & Therapy|October 31, 2019
The impact of sex and disease classification on patient-reported outcome measures in axial spondyloarthritis: a descriptive prospective cross-sectional studyRikke A Andreasen, Lars E Kristensen, Kenneth Egstrup, et al.
The Journal of Rheumatology|July 15, 2023
Report of the Skin Research Workgroups From the IDEOM Breakout at the GRAPPA 2022 Annual MeetingMelissa P Zundell, Michael J Woodbury, Kathryn Lee, et al.
RMD Open|November 2, 2019
Patient-reported outcomes for tofacitinib with and without methotrexate, or adalimumab with methotrexate, in rheumatoid arthritis: a phase IIIB/IV trialVibeke Strand, Eduardo Mysler, Robert J Moots, et al.
RMD Open|October 19, 2016
Tofacitinib versus methotrexate in rheumatoid arthritis: patient-reported outcomes from the randomised phase III ORAL Start trialVibeke Strand, Eun Bong Lee, Roy Fleischmann, et al.
Seminars in Arthritis and Rheumatism|May 24, 2012
Proceedings of the 2012 Rheumatology Winter Clinical SymposiaArthur Kavanaugh, George Martin, John J Cush, et al.
Rheumatology (Oxford, England)|November 26, 2013
Epratuzumab for patients with moderate to severe flaring SLE: health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE trials and extension study SL0006Vibeke Strand, Michelle Petri, Kenneth Kalunian, et al.
European Journal of Rheumatology|November 3, 2018
Comparative effectiveness of secukinumab and adalimumab in ankylosing spondylitis as assessed by matching-adjusted indirect comparisonWalter P Maksymowych, Vibeke Strand, Peter Nash, et al.
The American Journal of Medicine|May 27, 2008
Tumor necrosis factor antagonist responsiveness in a United States rheumatoid arthritis cohortJeffrey D Greenberg, Mitsumasa Kishimoto, Vibeke Strand, et al.
The Journal of Rheumatology|July 15, 2024
Report of the IDEOM Meeting Adjacent to the GRAPPA 2023 Annual MeetingGretchen D Ball, Danielle Yee, Arianna J Zhang, et al.
Rheumatology and Therapy|October 18, 2021
Patient-Reported Outcomes in Psoriatic Arthritis Patients with an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drugs: SELECT-PsA 2Vibeke Strand, Filip Van den Bosch, Roberto Ranza, et al.
Pageof 44